[Data],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lane,Sample_ID,Sample_Name,GenomeFolder,Index,bait_name,default_library_type,default_tag_sequence,default_tagtwo_sequence,email_addresses,email_addresses_of_followers,email_addresses_of_managers,email_addresses_of_owners,gbs_plex_name,is_control,is_pool,lane_id,lane_priority,library_name,organism,organism_taxon_id,project_cost_code,project_id,project_name,purpose,qc_state,request_id,required_insert_size_range,sample_accession_number,sample_cohort,sample_common_name,sample_consent_withdrawn,sample_control_type,sample_description,sample_donor_id,sample_id,sample_is_control,sample_name,sample_public_name,sample_reference_genome,sample_supplier_name,spiked_phix_tag_index,study_accession_number,study_alignments_in_bam,study_contains_nonconsented_human,study_contains_nonconsented_xahuman,study_description,study_id,study_name,study_reference_genome,study_separate_y_chromosome_data,study_title,tag_index,
1,64422,ERS005360,,ATCACG,,Standard,ATCACG,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042915PMEN1_64422,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005360,,Streptococcus pneumoniae,,,,,8727,,042915PMEN1,42915,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,1,
1,64424,ERS005368,,CGATGT,,Standard,CGATGT,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042935PMEN1_64424,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005368,,Streptococcus pneumoniae,,,,,8737,,042935PMEN1,42935,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,2,
1,64426,ERS005371,,TTAGGC,,Standard,TTAGGC,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042934PMEN1_64426,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005371,,Streptococcus pneumoniae,,,,,8736,,042934PMEN1,42934,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,3,
1,64428,ERS005367,,TGACCA,,Standard,TGACCA,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042932PMEN1_64428,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005367,,Streptococcus pneumoniae,,,,,8735,,042932PMEN1,42932,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,4,
1,64430,ERS005366,,ACAGTG,,Standard,ACAGTG,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042927PMEN1_64430,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005366,,Streptococcus pneumoniae,,,,,8734,,042927PMEN1,42927,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,5,
1,64432,ERS005369,,GCCAAT,,Standard,GCCAAT,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042926PMEN1_64432,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005369,,Streptococcus pneumoniae,,,,,8733,,042926PMEN1,42926,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,6,
1,64434,ERS005364,,CAGATC,,Standard,CAGATC,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042922PMEN1_64434,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005364,,Streptococcus pneumoniae,,,,,8732,,042922PMEN1,42922,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,7,
1,64438,ERS005363,,ACTTGA,,Standard,ACTTGA,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,063721PMEN1_64438,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005363,,Streptococcus pneumoniae,,,,,8730,,063721PMEN1,63721,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,8,
1,64440,ERS005361,,GATCAG,,Standard,GATCAG,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,052424PMEN1_64440,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005361,,Streptococcus pneumoniae,,,,,8729,,052424PMEN1,52424,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,9,
1,64442,ERS005365,,TAGCTT,,Standard,TAGCTT,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042917PMEN1_64442,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005365,,Streptococcus pneumoniae,,,,,8728,,042917PMEN1,42917,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,10,
1,64444,ERS005375,,GGCTAC,,Standard,GGCTAC,,dw2@sanger.ac.uk jm15@sanger.ac.uk ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,ko1@sanger.ac.uk nc3@sanger.ac.uk sb18@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,042937PMEN1_64444,Streptococcus pneumoniae PMEN1,1313,S0700,293,Streptococcus pneumoniae PMEN1,standard,,,from:200 to:200,ERS005375,,Streptococcus pneumoniae,,,,,8738,,042937PMEN1,42937,,,,ERP000139,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,293,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,,,Deep sequencing within the Streptococcus pneumoniae antibiotic resistant pandemic clone PMEN1,11,
2,82722,ERS1414766,,ATCACG,,Standard,ATCACG,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82722,S. gallinarium,594,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414766,,Salmonella enterica subsp. enterica serovar Gallinarum,,,,,8708,,SGal,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,1,
2,82721,ERS1414765,,CGATGT,,Standard,CGATGT,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82721,S. bongori,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414765,,Salmonella bongori,,,,,8707,,SBG,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,2,
2,82723,ERS1414767,,TTAGGC,,Standard,TTAGGC,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82723,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414767,,Salmonella bongori,,,,,9622,,dummy1,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,3,
2,82724,ERS1414768,,TGACCA,,Standard,TGACCA,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82724,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414768,,Salmonella bongori,,,,,9623,,dummy2,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,4,
2,82725,ERS1414769,,ACAGTG,,Standard,ACAGTG,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82725,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414769,,Salmonella bongori,,,,,9624,,dummy3,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,5,
2,82726,ERS1414770,,GCCAAT,,Standard,GCCAAT,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82726,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414770,,Salmonella bongori,,,,,9625,,dummy4,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,6,
3,82722,ERS1414766,,ATCACG,,Standard,ATCACG,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82722,S. gallinarium,594,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414766,,Salmonella enterica subsp. enterica serovar Gallinarum,,,,,8708,,SGal,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,1,
3,82721,ERS1414765,,CGATGT,,Standard,CGATGT,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82721,S. bongori,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414765,,Salmonella bongori,,,,,8707,,SBG,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,2,
3,82723,ERS1414767,,TTAGGC,,Standard,TTAGGC,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82723,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414767,,Salmonella bongori,,,,,9622,,dummy1,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,3,
3,82724,ERS1414768,,TGACCA,,Standard,TGACCA,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82724,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414768,,Salmonella bongori,,,,,9623,,dummy2,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,4,
3,82725,ERS1414769,,ACAGTG,,Standard,ACAGTG,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82725,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414769,,Salmonella bongori,,,,,9624,,dummy3,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,5,
3,82726,ERS1414770,,GCCAAT,,Standard,GCCAAT,,dw2@sanger.ac.uk gb4@sanger.ac.uk tfelt@sanger.ac.uk,gb4@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,SBG SGal multi trial 1 82726,,54736,S0700,238,Bongori Transcriptome sequencing,standard,,,from:200 to:200,ERS1414770,,Salmonella bongori,,,,,9625,,dummy4,,,,,ERP017996,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fsalmonella.html.%0A This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,238,Salmonella Bongori transcriptomics,,,Salmonella bongori transcriptomics,6,
4,79578,Multiplex-phix,,,,,,,,,,,,1,0,,0,Multiplex-phix,,,,,,standard,,46886,,,,,,,,,9837,,Multiplex-phix,,,,,,1,0,0,None,198,Illumina Controls,,,,,
5,59622,ERS003697,,CAGATC,,Standard,CAGATC,,dw2@sanger.ac.uk gr4@sanger.ac.uk jm15@sanger.ac.uk kh2@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,gr4@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,kh2@sanger.ac.uk,,0,0,,,TB 1797_03_59622,Mycobacterium tuberculosis,1773,S0700,206,Global TB - 100 strains,standard,,,from:500,ERS003697,,Mycobacterium tuberculosis,,,,,19,,TB 1797_03,,,,,ERP000124,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fmycobacterium.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,206,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),,,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),7,
5,59624,ERS003696,,ACTTGA,,Standard,ACTTGA,,dw2@sanger.ac.uk gr4@sanger.ac.uk jm15@sanger.ac.uk kh2@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,gr4@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,kh2@sanger.ac.uk,,0,0,,,TB 2-0014 _59624,Mycobacterium tuberculosis,1773,S0700,206,Global TB - 100 strains,standard,,,from:500,ERS003696,,Mycobacterium tuberculosis,,,,,20,,TB 2-0014 ,,,,,ERP000124,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fmycobacterium.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,206,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),,,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),8,
5,59626,ERS003698,,GATCAG,,Standard,GATCAG,,dw2@sanger.ac.uk gr4@sanger.ac.uk jm15@sanger.ac.uk kh2@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,gr4@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,kh2@sanger.ac.uk,,0,0,,,TB 2-0023 _59626,Mycobacterium tuberculosis,1773,S0700,206,Global TB - 100 strains,standard,,,from:500,ERS003698,,Mycobacterium tuberculosis,,,,,21,,TB 2-0023 ,,,,,ERP000124,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fmycobacterium.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,206,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),,,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),9,
5,59628,ERS003699,,TAGCTT,,Standard,TAGCTT,,dw2@sanger.ac.uk gr4@sanger.ac.uk jm15@sanger.ac.uk kh2@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,gr4@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,kh2@sanger.ac.uk,,0,0,,,TB 2-0036_59628,Mycobacterium tuberculosis,1773,S0700,206,Global TB - 100 strains,standard,,,from:500,ERS003699,,Mycobacterium tuberculosis,,,,,22,,TB 2-0036,,,,,ERP000124,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fmycobacterium.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,206,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),,,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),10,
5,59630,ERS003700,,GGCTAC,,Standard,GGCTAC,,dw2@sanger.ac.uk gr4@sanger.ac.uk jm15@sanger.ac.uk kh2@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,gr4@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,kh2@sanger.ac.uk,,0,0,,,TB 2-0504 _59630,Mycobacterium tuberculosis,1773,S0700,206,Global TB - 100 strains,standard,,,from:500,ERS003700,,Mycobacterium tuberculosis,,,,,23,,TB 2-0504 ,,,,,ERP000124,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fmycobacterium.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,206,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),,,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),11,
5,59632,ERS003701,,CTTGTA,,Standard,CTTGTA,,dw2@sanger.ac.uk gr4@sanger.ac.uk jm15@sanger.ac.uk kh2@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,gr4@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk jm15@sanger.ac.uk,kh2@sanger.ac.uk,,0,0,,,TB 2-0648 _59632,Mycobacterium tuberculosis,1773,S0700,206,Global TB - 100 strains,standard,,,from:500,ERS003701,,Mycobacterium tuberculosis,,,,,24,,TB 2-0648 ,,,,,ERP000124,1,0,0,For further information on this study please see http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fmycobacterium.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,206,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),,,Discovery of sequence diversity in Mycobacterium tuberculosis (100 strain global collection),12,
6,61586,ERS001648,,ATCACGATATCC,,Standard,ATCACGATATCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP119_61586,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001648,,Bordetella pertussis,,,,,5168,,BP119,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,1,
6,61588,ERS001649,,CGATGTATCTCC,,Standard,CGATGTATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP143_61588,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001649,,Bordetella pertussis,,,,,5169,,BP143,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,2,
6,61590,ERS001650,,TTAGGCATCTCC,,Standard,TTAGGCATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP7_61590,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001650,,Bordetella pertussis,,,,,5170,,BP7,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,3,
6,61592,ERS001651,,TGACCAATCTCC,,Standard,TGACCAATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP101_61592,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001651,,Bordetella pertussis,,,,,5171,,BP101,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,4,
6,61594,ERS001652,,ACAGTGATCTCC,,Standard,ACAGTGATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP227_61594,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001652,,Bordetella pertussis,,,,,5172,,BP227,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,5,
6,61596,ERS001653,,GCCAATATCTCC,,Standard,GCCAATATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP230_61596,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001653,,Bordetella pertussis,,,,,5173,,BP230,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,6,
6,61598,ERS001654,,CAGATCATCTCC,,Standard,CAGATCATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP279_61598,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001654,,Bordetella pertussis,,,,,5174,,BP279,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,7,
6,61600,ERS001655,,ACTTGAATCTCC,,Standard,ACTTGAATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP310_61600,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001655,,Bordetella pertussis,,,,,5175,,BP310,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,8,
6,61602,ERS001656,,GATCAGATCTCC,,Standard,GATCAGATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP317_61602,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001656,,Bordetella pertussis,,,,,5176,,BP317,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,9,
6,61604,ERS001657,,TAGCTTATCTCC,,Standard,TAGCTTATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP1_61604,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001657,,Bordetella pertussis,,,,,5177,,BP1,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,10,
6,61606,ERS001658,,GGCTACATCTCC,,Standard,GGCTACATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP6_61606,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001658,,Bordetella pertussis,,,,,5178,,BP6,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,11,
6,61608,ERS001659,,CTTGTAATCTCC,,Standard,CTTGTAATCTCC,,dw2@sanger.ac.uk mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,mq1@sanger.ac.uk sh16@sanger.ac.uk tfelt@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,BP2_61608,Bordetella pertussis,520,S0700,299,Bordetella sequencing project,standard,,,from:200 to:200,ERS001659,,Bordetella pertussis,,,,,5179,,BP2,,,,,ERP000331,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fbordetella.html This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F  Bordetella pertussis causes pertussis%2C a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s%2C and in recent years%2C a resurgence of disease was observed worldwide%2C with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs)%2C waning immunity%2C and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches%3B the largest of these contained 98%25 of all strains%2C and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage%2C suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. %0AFurthermore%2C our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However%2C many of the putative adaptive loci identified have a physiological role%2C and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. %0AWhooping cough is mainly caused by Bordetella pertussis%2C and current vaccines are targeted against this organism. Recently%2C there have been increasing outbreaks of whooping cough%2C even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years%2C consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction%2C potentially enabling vaccine escape.,299,Bordatella diversity project,Bordetella_pertussis (Tohama_I),,Bordetella diversity project,12,
7,87548,ERS008747,,ATCTCATCACGG,,Standard,ATCTCATCACGG,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Barts_03_flu 87548,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008747,,Influenzavirus A,,,,,10500,,Barts_03_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,1,
7,87549,ERS008748,,ATCTCCGATGTT,,Standard,ATCTCCGATGTT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Imp_01_flu 87549,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008748,,Influenzavirus A,,,,,10501,,Imp_01_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,2,
7,87552,ERS008751,,ATCTCTTAGGCC,,Standard,ATCTCTTAGGCC,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Imp_02_flu 87552,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008751,,Influenzavirus A,,,,,10504,,Imp_02_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,3,
7,87553,ERS008752,,ATCTCTGACCAA,,Standard,ATCTCTGACCAA,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,UCL_01_flu 87553,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008752,,Influenzavirus A,,,,,10505,,UCL_01_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,4,
7,87554,ERS008753,,ATCTCACAGTGG,,Standard,ATCTCACAGTGG,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,UCL_02_flu 87554,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008753,,Influenzavirus A,,,,,10506,,UCL_02_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,5,
7,87555,ERS008754,,ATCTCGCCAATT,,Standard,ATCTCGCCAATT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,UCL_03_flu 87555,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008754,,Influenzavirus A,,,,,10507,,UCL_03_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,6,
7,87556,ERS008755,,ATCTCCAGATCC,,Standard,ATCTCCAGATCC,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,H5N1_2_flu 87556,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008755,,Influenzavirus A,,,,,10508,,H5N1_2_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,7,
7,87557,ERS008756,,ATCTCACTTGAA,,Standard,ATCTCACTTGAA,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,H5N1_3_flu 87557,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008756,,Influenzavirus A,,,,,10509,,H5N1_3_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,8,
7,87558,ERS008757,,ATCTCGATCAGG,,Standard,ATCTCGATCAGG,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,H5N1_7_flu 87558,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008757,,Influenzavirus A,,,,,10510,,H5N1_7_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,9,
7,87559,ERS008758,,ATCTCTAGCTTT,,Standard,ATCTCTAGCTTT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,H5N1_9_flu 87559,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008758,,Influenzavirus A,,,,,10511,,H5N1_9_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,10,
7,87550,ERS008749,,ATCTCGGCTACC,,Standard,ATCTCGGCTACC,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,H5N1_11_flu 87550,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008749,,Influenzavirus A,,,,,10502,,H5N1_11_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,11,
7,87551,ERS008750,,ATCTCCTTGTAA,,Standard,ATCTCCTTGTAA,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,H5N1_14_flu 87551,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008750,,Influenzavirus A,,,,,10503,,H5N1_14_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,12,
8,87049,ERS008735,,ATCACGTTAT,,No PCR,ATCACGTTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,VLA_01_flu 87049,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008735,,Influenzavirus A,,,,,10488,,VLA_01_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,1,
8,87050,ERS008736,,CGATGTTTAT,,No PCR,CGATGTTTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,VLA_03_flu 87050,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008736,,Influenzavirus A,,,,,10489,,VLA_03_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,2,
8,87053,ERS008739,,TTAGGCATAT,,No PCR,TTAGGCATAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,CIDC_01_flu 87053,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008739,,Influenzavirus A,,,,,10492,,CIDC_01_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,3,
8,87054,ERS008740,,TGACCACTAT,,No PCR,TGACCACTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,CIDC_02_flu 87054,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008740,,Influenzavirus A,,,,,10493,,CIDC_02_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,4,
8,87055,ERS008741,,ACAGTGGTAT,,No PCR,ACAGTGGTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,CIDC_03_flu 87055,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008741,,Influenzavirus A,,,,,10494,,CIDC_03_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,5,
8,87056,ERS008742,,GCCAATGTAT,,No PCR,GCCAATGTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,CIDC_04_flu 87056,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008742,,Influenzavirus A,,,,,10495,,CIDC_04_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,6,
8,87057,ERS008743,,CAGATCTGAT,,No PCR,CAGATCTGAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Add_01_flu 87057,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008743,,Influenzavirus A,,,,,10496,,Add_01_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,7,
8,87058,ERS008744,,ACTTGATGAT,,No PCR,ACTTGATGAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Add_02_flu 87058,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008744,,Influenzavirus A,,,,,10497,,Add_02_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,8,
8,87059,ERS008745,,GATCAGCGAT,,No PCR,GATCAGCGAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Add_03_flu 87059,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008745,,Influenzavirus A,,,,,10498,,Add_03_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,9,
8,87060,ERS008746,,TAGCTTGTAT,,No PCR,TAGCTTGTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Add_04_flu 87060,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008746,,Influenzavirus A,,,,,10499,,Add_04_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,10,
8,87051,ERS008737,,GGCTACAGAT,,No PCR,GGCTACAGAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Barts_01_flu 87051,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008737,,Influenzavirus A,,,,,10490,,Barts_01_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,11,
8,87052,ERS008738,,CTTGTACTAT,,No PCR,CTTGTACTAT,,ap10@sanger.ac.uk dw2@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,ap10@sanger.ac.uk gb7@sanger.ac.uk pk5@sanger.ac.uk,dw2@sanger.ac.uk,ap10@sanger.ac.uk pk5@sanger.ac.uk,,0,0,,,Barts_02_flu 87052,Human Influenza Virus,197911,S0703,397,Influenza multiplex,standard,,,from:100 to:200,ERS008738,,Influenzavirus A,,,,,10491,,Barts_02_flu,,,,,ERP017907,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fviruses%2Forthomyxoviridae-influenzavirus-a.html,397,Virus Genome Influenza multiplex,,,Influenza multiplex,12,

